Close
Help





JOURNAL

Clinical Medicine Reviews in Therapeutics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2010:2

Review

Published on 16 Mar 2010

DOI: 10.4137/CMRT.S1600


Further metadata provided in PDF



Sign up for Email Alerts and keep in touch with Clinical Medicine Reviews in Therapeutics journal news, updates, events and articles

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Libertas Academica
Cancer Informatics has become an increasingly important source for research in the methodology of cancer genomics and the novel use of informatics technology. I have been impressed by the journal's contents and have been very gratified by the number of accesses to my recent publication. Cancer Informatics has filled an important gap in cancer research journals.
Dr Richard Simon (Chief, Biometric Research Branch, National Cancer Institute, USA )
More Testimonials

Quick Links


New article and journal news notification services